Table 2: Patients characteristics.
|
Case 1 |
Case 2 |
Case 3 |
Reference |
Age at diagnosis (years) |
64 |
64 |
48 |
|
Age at symptom onset (years) |
64 |
60 |
43 |
|
Race |
Caucasian |
Caucasian |
Caucasian |
|
Travel in classic KS areas (high prevalence HHV-8 areas) |
Yes |
Yes |
Yes |
|
Smoking |
No |
No |
No |
|
Sexual history |
MSM, HIV-negative partner, non-monogamous relationship |
MSM, HIV-positive partner (with undetectable viral load), monogamous relationship |
MSM, HIV-positive partner (with undetectable viral load), non-monogamous relationship |
|
Taking PrEP |
Yes |
No |
Yes |
|
Medical history |
No notable |
Syphilis |
Syphilis |
|
Comorbidities |
No notable |
Venous insufficiency, hypertension, liver fibrosis |
Recurrent genital herpes, hay fever |
|
Localization (number of cutaneous lesions) |
|
|
|
|
Lower limbs Upper limbs Mucosa Face and Neck Trunk |
5-20 1-5 0 0 1-5 |
> 50 5-10 0 0 0 |
1-5 1-5 0 0 5-10 |
|
Lymph node/visceral involvement |
No |
No |
No |
|
Systemic therapy need |
+/- |
Yes |
No |
|
Total lymphocytes (/μL) |
1880 |
1420 |
1880 |
1230-3420 |
B-lymphocytes (/μL) |
126 |
77 |
128 |
100-500 |
CD4 T-cells (/μL) |
748 |
542 |
641 |
300-1400 |
CD4/CD8 ratio |
1.10 |
1.58 |
0.90 |
1.0-3.6 |
Abnormal result are presented in bold
CD: Cluster of Differentiation; HHV-8: Human Herpes virus 8; HIV: Human Immunodeficiency Virus; KS: Kaposi Sarcoma; MSM: Men who have Sex with Men; PrEP: Pre-exposure Prophylaxis